Results 21 to 30 of about 1,561,985 (315)

Comparison of quality-adjusted life years (QALYs) of end-stage patients with gastrointestinal cancers receiving conventional therapies with recipients of supportive-palliative care package. [PDF]

J Family Med Prim Care
Vaziri S, Esfehani KJ, Hamidi R, Amiri H, Naghshbandi M, Rezai M, Mohammadi F.   +6 more
europepmc   +2 more sources

On cost-effectiveness analysis, quality-adjusted life years, and cost-effectiveness threshold values of gemcitabine plus nab-paclitaxel versus gemcitabine alone in metastatic pancreatic cancer in the French setting. [PDF]

Ther Adv Med Oncol
Lazzaro C.
europepmc   +2 more sources

Fair Funding Decisions: Consistency of the Time Horizons Used in the Calculation of Quality-Adjusted Life Years for Therapies for Very Rare Diseases by the National Institute for Health and Care Excellence in England. [PDF]

Int J Environ Res Public Health
Barman-Aksözen J, Hentschel N, Pettersson M, Schupp E, Granata F, Dechant C, Aksözen MH, Falchetto R.   +7 more
europepmc   +3 more sources

Office Examinations-Directed Treatment Paradigms Reduce Travel Burden, Decrease Treatment Cost, and Improve Quality-Adjusted Life-Years for Patients With Exudative Age-Related Macular Degeneration Undergoing Antivascular Endothelial Growth Factor Therapy. [PDF]

J Vitreoretin Dis, 2020
Emerson GG, Thompson JT, Vo LV, Mason RWH, Lee GD, Leder HA.   +5 more
europepmc   +3 more sources

Is the Use of DALYs and QALYs Ethically Permissible in Triage Decisions? COVID-19 and Equity Considerations from a Queer-Crip Perspective

Ethic@: an International Journal for Moral Philosophy, 2023
This paper explores the symbolic and material implications of the use of DALYs and QALYs as priority or tie-breaker criteria in triage decisions. It aims to answer the question of their ethical permissibility based on the particular case of the COVID-19
Lautaro Leani, Ignacio Mastroleo
doaj   +1 more source

Quality-Adjusted Life Years After Hip and Knee Arthroplasty: Health-Related Quality of Life After 12,782 Joint Replacements. [PDF]

JB JS Open Access, 2018
Konopka JF, Lee YY, Su EP, McLawhorn AS.
europepmc   +2 more sources

Cost Analysis of a Digital Multimodal Cancer Prehabilitation

Current Oncology, 2022
Introduction: There is growing evidence that prehabilitation programmes effectively improve the physical and psychological conditions of cancer patients awaiting treatment. During the pandemic, people with cancer were classed as vulnerable.
Evdoxia Gkaintatzi, Charoula Konstantia Nikolaou, Tarannum Rampal, Roberto Laza-Cagigas, Nazanin Zand, Paul McCrone   +5 more
doaj   +1 more source

Are Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities? [PDF]

Pharmacoeconomics, 2017
Mitchell PM, Venkatapuram S, Richardson J, Iezzi A, Coast J.   +4 more
europepmc   +4 more sources

Health economics and health preference concepts to orthopedics practitioners [PDF]

Acta Ortopédica Brasileira, 2014
The aim of this study was to describe concepts of health economics in order to update and provide the orthopedic practitioner decision making parameters based on preferences.
Carlos Delano Mundim Araújo, Daniela Francescato Veiga, Bernardo Hochman, Luiz Eduardo Felipe Abla, Neil Ferreira Novo, Lydia Masako Ferreira   +5 more
doaj   +1 more source

Multivariate risk preferences in the quality‐adjusted life year model [PDF]

Health Economics, 2021
AbstractThe interest in multivariate and higher‐order risk preferences has increased. A growing body of literature has demonstrated the relevance and impact of these preferences, but for health the evidence is lacking. We measure multivariate and higher‐order risk preferences for quality of life (QoL) and longevity, the two attributes of the Quality ...
Attema, Arthur E., Frasch, Jona J., L’haridon, Olivier   +2 more
openaire   +6 more sources